TGFB1 and cardiac hypertrophy: A reduction in SIRT1 expression leads to chronic and unopposed TGF‐β signaling through the activation of its receptor that causes the translocation of TGF‐β intermediates, namely Smad‐2 and Smad‐3, culminating in cardiac hypertrophy and fibrosis.121